$2.28
+0.06 (+2.70%)
Open$2.23
Previous Close$2.22
Day High$2.34
Day Low$2.22
52W High$7.40
52W Low$2.06
Volume—
Avg Volume53.6K
Market Cap35.95M
P/E Ratio—
EPS$-1.20
SectorPharmaceuticals
Analyst Ratings
Strong Buy
8 analysts
Price Target
+1,543.9% upside
Current
$2.28
$2.28
Target
$37.48
$37.48
$21.76
$37.48 avg
$51.92
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 19.74M | 30.34M | 6.59M |
| Net Income | -44,195,035 | -61,117,903 | 1.64M |
| Profit Margin | -223.9% | -212.7% | 24.9% |
| EBITDA | -42,044,179 | -61,373,647 | 3.19M |
| Free Cash Flow | — | — | 1.30M |
| Rev Growth | -34.9% | -34.9% | +19.2% |
| Debt/Equity | — | — | 0.45 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $948.45 | -2.72% | 36.1 | 913.24B |
| JNJ | Johnson & Johnson | $221.32 | -0.53% | 26.1 | 548.94B |
| MRK | Merck & Co. Inc. | $111.38 | -0.82% | 31.3 | 279.42B |
| PFE | Pfizer Inc. | $25.68 | -3.02% | 19.3 | 150.09B |
| BMY | Bristol-Myers Squibb Co | $56.16 | -0.16% | 17.0 | 120.08B |
| ZTS | Zoetis Inc | $82.83 | -5.13% | 21.5 | 57.37B |